ArticleKidney3602026

Dapagliflozin Reduces Kidney Inflammation in Alport Syndrome by Inhibiting the Stimulator of IFN Genes Pathway in Renal Tubular Epithelial Cells.

Qimin Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.